We have identified you may not be viewing TRAVAX optimally because the browser you are using is unsupported - click here.
We have identified you may not be viewing TRAVAX optimally because the browser you are using is unsupported - click here.
A new meningococcal conjugate vaccine has been launched in the UK by Glaxo SmithKline. Nimenrix™ helps protect against invasive meningococcal disease caused by the bacterium Neisseria meningitidis (groups A, C, W-135 and Y).
Nimenrix™ can be given to individuals from 12 month-of-age and includes those who may have previously received meningococcal ACWY polysaccharide vaccine.
